Act 65 tasks the CCB, in consultation with stakeholders, to make recommendations about Vermont’s medical cannabis program, including:
- The conditions that should qualify for medical cannabis
- Which strains are appropriate for a given condition
- Dosing and other treatment standards
- Any other recommendations that might improve the program
The study committee will meet four times over the summer and fall. All meetings will be open to remote public attendance. The first meeting will occur on Tuesday, August 8, 2023.
Agenda and remote meeting information may be found here: